Skip to main content

GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine

Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.